Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. Cash on Hand 2020–2022
Cullinan Therapeutics, Inc. annual/quarterly cash on hand history from 2020 to 2022. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Cullinan Therapeutics, Inc. cash on hand for the quarter ending December 31, 2022 were 156.2M, a 161.24% increase year-over-year.
- Cullinan Therapeutics, Inc. cash on hand for 2022 were 156.2M, a 161.24% increase from 2021.
- Cullinan Therapeutics, Inc. cash on hand for 2021 were 59.8M, a 64.46% decrease from 2020.
- Cullinan Therapeutics, Inc. cash on hand for 2020 were 168.2M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cullinan Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2022 | $156 |
| 2021 | $60 |
| 2020 | $168 |
| Cullinan Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2022-12-31 | $156 |
| 2021-12-31 | $60 |
| 2020-12-31 | $168 |
Cullinan Therapeutics, Inc. Cash on Hand — FAQ
Cullinan Therapeutics, Inc. (CGEM) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGEM's cash on hand history?
The chart and table above show Cullinan Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.